Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery.

Autor: Pucher PH; Guy's & St Thomas' NHS Foundation Trust, London, UK.; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Coombes A; Guy's & St Thomas' NHS Foundation Trust, London, UK., Evans O; Guy's & St Thomas' NHS Foundation Trust, London, UK., Taylor J; Guy's & St Thomas' NHS Foundation Trust, London, UK., Moore JL; Guy's & St Thomas' NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., White A; Guy's & St Thomas' NHS Foundation Trust, London, UK., Lagergren J; Guy's & St Thomas' NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Baker C; Guy's & St Thomas' NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Kelly M; Guy's & St Thomas' NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Gossage JA; Guy's & St Thomas' NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Dunn J; Guy's & St Thomas' NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Zeki S; Guy's & St Thomas' NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Byrne BE; Centre for Surgical Research, University of Bristol, Bristol, UK., Andreyev J; United Lincolnshire Hospitals Trust & The School of Medicine, University of Nottingham, Nottingham, UK., Davies AR; Guy's & St Thomas' NHS Foundation Trust, London, UK. Andrew.davies1@gstt.nhs.uk.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. Andrew.davies1@gstt.nhs.uk.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Andrew.davies1@gstt.nhs.uk.; Department of Surgery, St Thomas' Hospital, Westminster Bridge Road, SE1 7EH, London, UK. Andrew.davies1@gstt.nhs.uk.
Jazyk: angličtina
Zdroj: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Jun; Vol. 30 (6), pp. 5269-5275. Date of Electronic Publication: 2022 Mar 11.
DOI: 10.1007/s00520-022-06922-w
Abstrakt: Purpose: Long-lasting symptoms and reductions in quality of life are common after oesophago-gastric surgery. Post-operative follow-up has traditionally focussed on tumour recurrence and survival, but there is a growing need to also identify and treat functional sequelae to improve patients' recovery.
Methods: An electronic survey was circulated via a British national charity for patients undergoing oesophago-gastric surgery and their families. Patients were asked about post-operative symptoms they deemed important to their quality of life, as well as satisfaction and preferences for post-operative follow-up. Differences between satisfied and dissatisfied patients with reference to follow-up were assessed.
Results: Among 362 respondents with a median follow-up of 58 months since surgery (range 3-412), 36 different symptoms were reported as being important to recovery and quality of life after surgery, with a median of 13 symptoms per patient. Most (84%) respondents indicated satisfaction with follow-up. Satisfied patients were more likely to have received longer follow-up (5-year or longer follow-up 60% among satisfied patients vs 27% among unsatisfied, p < 0.001). These were also less likely to have seen a dietitian as part of routine follow-up (37% vs 58%, p = 0.005).
Conclusion: This patient survey highlights preferences regarding follow-up after oesophago-gastrectomy. Longer follow-up and dietician involvement improved patient satisfaction. Patients reported being concerned by a large number of gastrointestinal and non-gastrointestinal symptoms, highlighting the need for multidisciplinary input and a consensus on how to manage the poly-symptomatic patient.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz: